EXOBIOSPHERE was founded in 2024 in Luxembourg with the vision of transforming the drug discovery process. Recognizing the unique advantages of microgravity environments, EXOBIOSPHERE aims to provide a platform to unlock new insights into cellular behaviors that are not observable under Earth's gravity.
EXOBIOSPHERE builds bridges between Earth and space, catalyzing rapid, cost-effective breakthroughs in pharmaceuticals, skincare, and nutrition.
We streamline space-based research offering an efficient, dependable and safe gateway for our clients in microgravity.
Extend and Improve Life on Earth and in Space.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.